Navigation Links
BodySculpt(TM) Leads FDA Approval of BodyTite(TM) with Largest Number of Documented Study Cases
Date:9/16/2009

NEW YORK, Sept. 16 /PRNewswire/ -- The plastic surgeons at BodySculpt(TM) are revolutionizing the latest techniques in liposuction -- one radio-frequency wave at a time. Since being selected by Invasix to head the FDA approval studies of BodyTite(TM), BodySculpt(TM) has lead the industry in its number of case studies and field research. The latest device in body-contouring procedures, BodyTite(TM) utilizes radio-frequency assisted liposuction (RFAL) technology. With the direction of board certified BodySculpt(TM) Surgical Director Dr. Christopher Chia BodySculpt(TM) is the first team of surgeons in the New York area to use BodyTite(TM) and is the leading authority in RFAL and its introduction to the world of plastic surgery.

BodyTite(TM) is the most compact and ergonomic, energy-assisted liposuction device in the world, in addition to being powerful, minimally invasive and safe. BodyTite(TM) liposuction procedures not only produce successful fat removal with less downtime, but also improve patient safety and comfort.

After conducting several case studies on women with postpartum body insecurities, the plastic surgeons at BodySculpt(TM) have even deemed it as the "virtual no scar tummy-tuck". The RFAL technology induces simultaneous tissue liquefaction, blood vessel coagulation, and heating of the skin, which results in optimal soft tissue contraction and skin tightening. This makes the procedure ideal for postpartum patients or others with compromised skin laxity, such as those who have just experienced extreme weight loss.

Having conducted the largest number of study cases of the procedure in the US, the impressive findings of the doctors at BodySculpt(TM) will aide in determining industry-wide effectiveness and safety standards of BodyTite(TM) once approved by the FDA. Results, reactions, and conclusions thus far have been extremely positive and successful- great news for the FDA approval process, potential patients and surgeons alike.


'/>"/>
SOURCE BodySculpt
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. San Ramon HR Firm Leads Response to New Cal/OSHA ATD Law
2. Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder
3. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
4. Pharmaleads Lead Candidate for Pain, PL37, Enters Phase I
5. Discovery Leads to Earlier Diagnosis of Type 1 Diabetes
6. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
7. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
8. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
9. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
10. ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis
11. WorldHeart Receives US Clinical Study Approval for the Levacor(TM) VAD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 29, 2017   Dynatronics Corporation (NASDAQ: ... of Cynthia L. McHenry (Cyndi) as ... for leading Dynatronics manufacturing, distribution, and purchasing operations ... Dynatronics, CEO Kelvyn H. Cullimore, Jr. ... search process conducted by the company as it ...
(Date:3/29/2017)... 29, 2017 On March 28, the U.S. Food and ... with relapsing forms of multiple sclerosis (MS) and primary ... approved by the FDA for PPMS. Ocrevus is an ... "Multiple sclerosis can have a profound impact ... M.D., director of the Division of Neurology Products in ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - Medicure Inc. ... release financial results for the year ended December ... 26, 2017. The results are being released later ... financial statements will include the operations and balances ... 1, 2016.  This release and filing date meets ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... Dr. Angela Cotey, a noted general dentist in Mt. Horeb, ... with or without a referral. Dr. Cotey knows that interceptive orthodontics in ... When patients receive early treatment, they may achieve straight teeth with less treatment in ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a premium medical ... of the company’s executive management team with prominent executives from both inside and outside ... Chief Operating Officer, Ted Dumbauld , who has more than twenty years of ...
(Date:3/29/2017)... ... , ... Immunotherapy has emerged as one of the most promising options for ... the next revolution in our fight against this complex disease. One of the most ... inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single analyte immunohistochemistry ...
(Date:3/29/2017)... , ... March 29, 2017 , ... The Wharton School ... and Julie Taffet Moelis, W’81, have made a $10 million gift to establish the ... opportunity that will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates ...
(Date:3/28/2017)... Los Angeles, CA (PRWEB) , ... March 28, 2017 , ... ... “wake-up call” asking the American public to take the Diabetes Risk Test to find ... the event, the Los Angeles World Airports will light up the evening sky by ...
Breaking Medicine News(10 mins):